Article Information
History
- September 9, 2019.
Article Versions
- Version 1 (February 5, 2019 - 12:39).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Andrew L. Hook1,
- James L. Flewellen2,3,4,
- Jean-Frédéric Dubern5,
- Alessandro Carabelli1,5,
- Irwin M. Zaid4,
- Richard M. Berry4,
- Ricky Wildman6,
- Noah Russell7,
- Paul Williams5,* and
- Morgan R. Alexander1,*
- 1Advanced Materials and Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham NG7 RD, United Kingdom
- 2Immune Receptor Activation Laboratory, The Francis Crick Institute, London NW1 1AT, United Kingdom
- 3Division of Immunology and Inflammation, Department of Medicine, Imperial College London, London SW7 2A2, United Kingdom
- 4Department of Physics, Clarendon Laboratory, University of Oxford, Parks Road, Oxford OX1 3PU, United Kingdom
- 5Centre for Biomolecular Sciences, School of Life Sciences, University of Nottingham, Nottingham NG7 2RD, United Kingdom
- 6Department of Chemical and Environmental Engineering, School of Engineering, University of Nottingham, Nottingham NG7 2RD, United Kingdom
- 7Marine Biological Association, The Laboratory, Citadel Hill, Plymouth, Devon, PL1 2PB, United Kingdom
- ↵* Joint Corresponding Authors paul.williams{at}nottingham.ac.uk, morgan.alexander{at}nottingham.ac.uk